Editorial: Small molecules and smart drug delivery systems for combination cancer immunotherapy

Editorial: Small molecules and smart drug delivery systems for combination cancer immunotherapy

Bibliographic Details
Main Authors:	Claudia Ferroni, Greta Varchi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-04-01
Series:	Frontiers in Chemistry
Subjects:	cancer immunotherapy combined treatment targeted therapy delivery systems
Online Access:	https://www.frontiersin.org/articles/10.3389/fchem.2024.1412624/full

Similar Items

Keratin-Based Nanoparticles as Drug Delivery Carriers
by: Claudia Ferroni, et al.
Published: (2021-10-01)

Smart Nanocarriers for the Targeted Delivery of Therapeutic Nucleic Acid for Cancer Immunotherapy
by: Abu Baker, et al.
Published: (2023-06-01)

Targeted Microbubbles for Drug, Gene, and Cell Delivery in Therapy and Immunotherapy
by: J. Angel Navarro-Becerra, et al.
Published: (2023-05-01)

Clinical research progress of targeted therapy combined with immunotherapy for advanced cholangiocarcinoma
by: Qin Liu, et al.
Published: (2023-01-01)

Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview
by: Xu Liu, et al.
Published: (2024-01-01)

Exosomes as smart drug delivery vehicles for cancer immunotherapy
by: Huan Zhang, et al.
Published: (2023-01-01)

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies
by: Yanyang Nan, et al.
Published: (2023-08-01)

Smart drug delivery systems to overcome drug resistance in cancer immunotherapy
by: Wenzhe Yi, et al.
Published: (2023-04-01)

Injectable DNA Hydrogel-Based Local Drug Delivery and Immunotherapy
by: Qi Wang, et al.
Published: (2022-06-01)

Immunotherapy for Triple-Negative Breast Cancer
by: Yifeng Cao, et al.
Published: (2021-11-01)

Small-Molecule PROTACs for Cancer Immunotherapy
by: Zefan Liu, et al.
Published: (2022-08-01)

Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
by: Zili Gu, et al.
Published: (2020-11-01)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
by: Shuqi Xie, et al.
Published: (2023-05-01)

Cytokine Therapy Combined with Nanomaterials Participates in Cancer Immunotherapy
by: Heping Lian, et al.
Published: (2022-11-01)

Gold Nanoparticles: Construction for Drug Delivery and Application in Cancer Immunotherapy
by: Huiqun Huang, et al.
Published: (2023-07-01)

Systemically targeted cancer immunotherapy and gene delivery using transmorphic particles
by: Paladd Asavarut, et al.
Published: (2022-08-01)

Corrigendum: Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
by: Shuqi Xie, et al.
Published: (2023-12-01)

Tackling Immunotherapy Resistance: Developing Rational Combinations of Immunotherapy and Targeted Drugs
by: Elena Cojocaru, et al.
Published: (2019-05-01)

Editorial: Anti-cancer bioactive molecules from microbial sources
by: Bishwambhar Mishra, et al.
Published: (2023-04-01)

Roles of exosomes as drug delivery systems in cancer immunotherapy: a mini-review
by: Zhen Fang, et al.
Published: (2022-08-01)

THE PROGNOSTIC MODEL OF ANTITUMOR EFFECT OF TARGETED DRUGS IN IMMUNOTHERAPY
by: V. V. Burlyaev, et al.
Published: (2016-08-01)

Engineering Smart Targeting Nanovesicles and Their Combination with Hydrogels for Controlled Drug Delivery
by: Kamil Elkhoury, et al.
Published: (2020-09-01)

A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers
by: Safiye Akkın, et al.
Published: (2021-06-01)

From structural design to delivery: mRNA therapeutics for cancer immunotherapy
by: Feng Zhou, et al.
Published: (2024-04-01)

Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
by: Clare Y. Slaney, et al.
Published: (2023-01-01)

Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative “cold” triple-negative breast cancer
by: Beibei Guo, et al.
Published: (2023-07-01)

Nanocarrier-Based Drug Delivery for Melanoma Therapeutics
by: Mingming Song, et al.
Published: (2021-02-01)

Engineering a facile and versatile nanoplatform to facilitate the delivery of multiple agents for targeted breast cancer chemo-immunotherapy
by: Amirhossein Bahreyni, et al.
Published: (2023-07-01)

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
by: Yujeong Moon, et al.
Published: (2023-01-01)

Combined Nano-Vector Mediated-Transfer to Suppress HIV-1 Infection with Targeted Antibodies in-vitro
by: Yao X, et al.
Published: (2023-08-01)

Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
by: Dhruv Bansal, et al.
Published: (2021-01-01)

Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics
by: Lili Zhou, et al.
Published: (2022-05-01)

Nanomaterial‐Boosted Tumor Immunotherapy Through Natural Killer Cells
by: Mengsi Zhan, et al.
Published: (2022-12-01)

Targeted Therapy and Immunotherapy for Heterogeneous Breast Cancer
by: Xiaolu Sun, et al.
Published: (2022-11-01)

Editorial: Immunotherapy and small molecule inhibitors as combinational cancer therapeutics
by: Mohd Wajid Ali Khan, et al.
Published: (2023-08-01)

Cancer Immunotherapy and Delivery System: An Update
by: Ming Yang, et al.
Published: (2022-08-01)

Progression in immunotherapy for advanced prostate cancer
by: Hao Liang, et al.
Published: (2023-02-01)

Activation of cancer immunotherapy by nanomedicine
by: Lijuan Wang, et al.
Published: (2022-12-01)

Nanomaterial-Based Drug Delivery Systems: A New Weapon for Cancer Immunotherapy
by: Jiang Z, et al.
Published: (2022-10-01)

A ROS-responsive synergistic delivery system for combined immunotherapy and chemotherapy
by: Doudou Hu, et al.
Published: (2022-03-01)